[1] Peerapen P, Thongboonkerd V.Kidney stone prevention[J]. Adv Nutr, 2023, 14(3): 555-569. [2] Desai J, Shah HN.Mini percutaneous kidney stone removal: Applicable technologies[J]. Urol Clin North Am, 2022, 49(1): 161-173. [3] Chewcharat A, Thongprayoon C, Vaughan LE, et al.Dietary risk factors for incident and recurrent symptomatic kidney stones[J]. Mayo Clin Proc, 2022, 97(8): 1437-1448. [4] Dhayat NA, Bonny O, Roth B, et al.Hydrochlorothiazide and prevention of kidney-stone recurrence[J]. N Engl J Med, 2023, 388(9): 781-791. [5] Kulsoom, Ahmad S, Urwa, et al. Associations between clinical, biochemical, and nutritional factors in kidney stone formation and recurrence[J]. Urolithiasis, 2025, 53(1): 112. [6] 徐磊,车宪平,古军,等. 肾结石患者术后泌尿系感染与结石复发的影响因素及相关性研究[J]. 中华医院感染学杂志,2018,28(21):3278-3281,3296. [7] 陈孝平,汪建平,赵继宗. 外科学[M]. 9版. 北京:人民卫生出版社,2018:558-562. [8] 武永强,刘晓彤,罗飞. 血清及尿液中丛生蛋白和血清炎症因子水平的变化与肾结石发病的相关性分析[J]. 医学临床研究,2020,37(4):542-544. [9] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志,2021,13(4):315-409. [10] 中华医学会,中华医学杂志社,中华医学会全科医学分会,等. 高血压基层诊疗指南(2019年)[J]. 中华全科医师杂志,2019,18(4):301-313. [11] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 血脂异常基层诊疗指南(2019年)[J]. 中华全科医师杂志,2019,18(5):406-416. [12] Fan X, Ye W, Ma J, et al.Metabolic differences between unilateral and bilateral kidney stones and their association with markers of kidney injury[J]. J Urol, 2022, 207(1): 144-151. [13] 赵发燕,何秉勋,赵丽,等. 基于LASSO-COX回归构建肾结石复发风险护理评估模型[J]. 四川医学,2020,41(4):424-429. [14] Finger M, Finger E, Bellucci A, et al.Medical management for the prevention of kidney stones[J]. Postgrad Med J, 2023, 99(1169): 112-118. [15] 杨帆,毛立军,石留锁. 输尿管软镜碎石术后肾结石复发的影响因素及其与预后营养指数的相关性[J]. 海南医学,2025,36(10):1431-1436. [16] 顾鑫,景立伟,王岸迪,等. 肾结石腔内碎石术后结石复发率及危险因素分析[J]. 实用临床医药杂志,2024,28(10):39-41. [17] Paik JM, Tesfaye H, Curhan GC, et al.Sodium-glucose cotransporter 2 inhibitors and nephrolithiasis risk in patients with type 2 diabetes[J]. JAMA Intern Med, 2024, 184(3): 265-274. [18] 阿力木江•阿不都热西提,张宁,甘之录,等. 学龄前儿童肾结石成分分析及结石复发相关危险因素分析[J]. 临床泌尿外科杂志,2021,36(2):135-138. [19] Bargagli M, Scoglio M, Howles SA, et al.Kidney stone disease: Risk factors, pathophysiology and management[J]. Nat Rev Nephrol, 2025, 21(11): 794-808. [20] Bai S, Zhang Y, Guo C, et al.Associations between dietary patterns and nephrolithiasis risk in a large Chinese cohort: Is a balanced or plant-based diet better?[J]. Food Funct, 2023, 14(7): 3220-3229. [21] Shan L, Shi J, Li J, et al.Associations between grain intake and hospitalized nephrolithiasis in Chinese adults: A case-control study[J]. Food Funct, 2023, 14(8): 3863-3870. [22] Hakam N, Guzman Fuentes JL, Nabavizadeh B, et al.Outcomes in randomized clinical trials testing changes in daily water intake: A systematic review[J]. JAMA Netw Open, 2024, 7(11): e2447621. [23] 陈芳芳. 肾结石微创术后复发风险模型构建及护理干预研究[J]. 蚌埠医学院学报,2021,46(8):1133-1137. [24] 杜建辉,蓝建华,兰东,等. 肾结石患者术后泌尿系感染与结石复发的影响因素分析[J]. 国际泌尿系统杂志,2022,42(4):651-655. [25] Jones-Freeman B, Chonwerawong M, Marcelino VR, et al.The microbiome and host mucosal interactions in urinary tract diseases[J]. Mucosal Immunol, 2021, 14(4): 779-792. [26] Song Q, Song C, Chen X, et al.FKBP5 deficiency attenuates calcium oxalate kidney stone formation by suppressing cell-crystal adhesion, apoptosis and macrophage M1 polarization via inhibition of NF-κB signaling[J]. Cell Mol Life Sci, 2023, 80(10): 301. [27] 何语实,王孟华,简钟宇,等. 预后营养指数与肾结石发病风险的关联性分析:基于NHANES的数据分析结果[J]. 临床泌尿外科杂志,2023,38(1):48-52. [28] Khan SR, Canales BK, Dominguez-Gutierrez PR.Randall's plaque and calcium oxalate stone formation: Role for immunity and inflammation[J]. Nat Rev Nephrol, 2021, 17(6): 417-433. |